|
|
|
Feed Submission If you'd like OHCNetwork Health News to link to your health news or blog from this category (Bipolar - Mental Diseases - Diseases and Conditions), please submit your RSS or XML feed to OHCNetwork Health News. Contact information is available here. |
Health News >> Diseases and Conditions >> Mental Diseases >> Bipolar
Bipolar News
Bipolar News From Medical News Today
Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval - a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it. But a potential game plan now exists.
Bipolar News From Medical News Today
Neuroscientists at the Indiana University School of Medicine have created the first comprehensive map of genes likely to be involved in bipolar disorder, according to research published online Nov. 21 in the American Journal of Medical Genetics. The researchers combined data from the latest large-scale international gene hunting studies for bipolar disorder with information from their own studies and have identified the best candidate genes for the illness.
Bipolar News From Medical News Today
Neuroscientists at the Indiana University School of Medicine have created the first comprehensive map of genes likely to be involved in bipolar disorder, according to research published online Nov. 21 in the American Journal of Medical Genetics. The researchers combined data from the latest large-scale international gene hunting studies for bipolar disorder with information from their own studies and have identified the best candidate genes for the illness.
Bipolar News From Medical News Today
Psychiatrist Dr. Frederick K. Goodwin, host to the popular radio program The Infinite Mind, has lost his radio hosting job after Senator Charles E. Grassley revealed that he had received $1.3 million from pharmaceutical companies during the period 2000-2007. Dr. Goodwin used to be director of the National Institute of Mental Health. How widespread this practice has been among media figures is unclear, as Dr. Goodwin is just the first one to be investigated.
Bipolar News From Medical News Today
Clinicians and researchers from around the world attended this week's 8th International Forum on Mood and Anxiety disorders in Vienna, Austria to discuss the latest advances in the treatment of mood disorders. A wide range of topics were included in this year's programme, highlighting the position of IFMAD in the congress calendar as a forum for breaking news, original thinking and debate.
Bipolar News From Medical News Today
Lipocine Inc., a specialty pharmaceutical company that uses clinically validated proprietary technologies to address key unmet drug delivery and therapeutic needs, today announced the successful completion of a clinical study that establishes feasibility of the first once-a-day dosing product for Ziprasidone, a leading treatment for schizophrenia and bipolar disorder. - Schizophrenia affects 1% of the population and bipolar disorder affects 5.7M adults in the US*.
Bipolar News From Medical News Today
AstraZeneca today announced that the once-daily formulation SEROQUEL XR? (quetiapine fumarate extended release tablets) and SEROQUEL® (quetiapine fumarate) have been approved via the Mutual Recognition Procedure for new indications in bipolar disorder. SEROQUEL XR and SEROQUEL have been approved for treatment of major depressive episodes in bipolar disorder. Additionally, SEROQUEL XR has been approved for treatment of moderate to severe manic episodes in bipolar disorder.
Bipolar News From Medical News Today
Repligen Corporation (Nasdaq: RGEN) announced that the Company has initiated a Phase 2b clinical trial to evaluate the use of RG2417, an oral formulation of uridine, in patients with bipolar depression. This Phase 2b study is a multi-center, randomized, double-blind, placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or placebo twice daily for eight weeks.
Bipolar News From Medical News Today
About 1.4 million hospitalizations in 2006 involved patients who were admitted for a mental illness, while another 7.1 million patients had a mental disorder in addition to the physical condition for which they were admitted, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The 8.5 million hospitalizations involving patients with mental illness represented about 22 percent of the overall 39.5 million hospitalizations in 2006.
Bipolar News From Medical News Today
A study carried out in the Institute of Neurosciences of the University of Granada (Spain) and the Mental Health Unit of the Hospital Neurotraumatológico of Jaen (Spain) has evaluated the quality of life of patients suffering from bipolar disorder (BD), in comparison with the general population, and which variables are connected with patients with a lower quality of life.
Bipolar News From Medical News Today
Impulsiveness can be a common feature of mania, particularly the inability to inhibit behavioral responses. This neuroimaging study examined bipolar patients during their first episode of mania to clarify the brain functioning associated with response inhibition in this early phase of illness. 16 first-episode bipolar patients and 16 healthy subjects were underwent functional MRI scanning (fMRI) while performing a response inhibition task.
Bipolar News From Medical News Today
This press release is available in French and Spanish.
Bipolar News From Medical News Today
One in 50 people in England were in contact with NHS specialist services for those with severe or enduring mental health problems in 2006-07, according to a new report by The NHS Information Centre. The number accessing specialist services, which cover care by specialist psychiatric teams in hospital or in the community, has risen over the four years covered by the report, reaching more than 1.1 million in 2006-07.
Bipolar News From Medical News Today
Mental illness is one of the last surviving stigmas in today's liberal society. Class, race, religion, gender and sexual orientation, are all off-limits now as reasons for discrimination, social exclusion, jokes or disparaging remarks of any kind. Where these are concerned, we've come a long way in terms of tolerance, fairness and sensitivity to the feelings of others; as a rule, words are chosen carefully so as not to offend and legislation ensures fair treatment.
Bipolar News From Medical News Today
Commenting on the Annual Health check, Lisa Rodrigues, Chair of the
Bipolar News From Medical News Today
Acne and attention deficit hyperactivity disorder (ADHD) patients are the condition groups most likely to watch streaming or downloaded television programs on the Internet, according to pharmaceutical and healthcare market research company Manhattan Research's just released Cybercitizen® Health v8.0 consumer study and strategic advisory service. The study also found that consumer media preferences overall are evolving - less than half of U.S.
Bipolar News From Medical News Today
The Mood Disorders Association of Ontario (MDAO) today launches "It's All In Your Head!" an initiative to promote awareness of the work of the MDAO and dispel myths about mental illness. Volunteers will be in the Yonge-Eglinton subway station and the Yonge-Eglinton Centre to hand out "heady" information to commuters during the evening rush hour. Mood disorders, such as depression and bipolar disorder will affect one in five individuals at some point in their life.
Bipolar News From Medical News Today
Young adults who had bipolar disorder as children are likely to suffer from manic episodes, according to an article released on October 6, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals. Bipolar disorder is a severe mood disorder that involves episodes of mania and depression. There is significant debate about how pediatric bipolar disorder, which affects children, should be diagnosed.
Bipolar News From Medical News Today
Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc announced preliminary top-line results from a phase II clinical trial of cariprazine (RGH-188), an investigational antipsychotic, in patients with acute mania associated with bipolar I disorder.
Bipolar News From Medical News Today
Thirty seven medical experts in psychiatry from across the world have called on the medical community to take urgent action to optimize services for people with a diagnosis of severe mental illness such as schizophrenia or bipolar disorder(i). Professor W.
Bipolar News From Medical News Today
Seroquel XL (quetiapine prolonged release) a new, once daily formulation for schizophrenia and manic episodes associated with bipolar disorder, has today become available in the UK.[1] The new formulation was developed to address the needs of patients who require effective control of symptoms in a once daily rather than twice daily tablet.
Bipolar News From Medical News Today
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant drugs first line. The new report entitled Treatment Algorithms in Bipolar Disorder finds that this high preponderance of early-line antidepressant use stems from primary care physician prescribing.
Bipolar News From Medical News Today
German researchers have devised a way to follow gene expression over time in a 64-year-old woman who developed rapid-cycling bipolar illness in her mid-40s. Over a 16-year period, the woman logged in 108 cycles in her diary. Rapid-cycling bipolar illness is characterized by four or more episodes of depression and/or mania in a given year.
Bipolar News From Medical News Today
Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced that following a hearing on September 12, 2008, the U.S. Court of Appeals for the District of Columbia has vacated an April 2008 ruling, which granted Teva 180-day exclusivity for its Risperidone Tablets, AB-rated to Janssen's Risperdal® Tablets. As a result of this decision, the U.S. Food and Drug Administration is no longer enjoined from approving subsequent Abbreviated New Drug Applications (ANDA).
Bipolar News From Medical News Today
Today, Seroquel XL (quetiapine prolonged release), a new once daily formulation for schizophrenia and manic episodes associated with bipolar disorder, has become available in the UK.1 AstraZeneca has developed the new formulation of its atypical antipsychotic treatment to meet the needs of patients for whom a once daily dose is preferred and/or for whom1 effective control of symptoms is important.
| ||||||||||||||||||
| ||||||||||||||||||